The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ochoa-Repáraz, J.
Right arrow Articles by Pascual, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ochoa-Repáraz, J.
Right arrow Articles by Pascual, D. W.
The Journal of Immunology, 2007, 178: 1791-1799.
Copyright © 2007 by The American Association of Immunologists, Inc.

Regulatory T Cell Vaccination without Autoantigen Protects against Experimental Autoimmune Encephalomyelitis1

Javier Ochoa-Repáraz, Carol Riccardi, Agnieszka Rynda, SangMu Jun, Gayle Callis and David W. Pascual2

Veterinary Molecular Biology, Montana State University, Bozeman, MT 59717

Regulatory T (Treg) cells show promise for treating autoimmune diseases, but their induction to elevated potency has been problematic when the most optimally derived cells are from diseased animals. To circumvent reliance on autoantigen-reactive Treg cells, stimulation to myelin-independent Ags may offer a viable alternative while maintaining potency to treat experimental autoimmune encephalomyelitis (EAE). The experimental Salmonella vaccine expressing colonization factor Ag I possesses anti-inflammatory properties and, when applied therapeutically, reduces further development of EAE in SJL mice. To ascertain Treg cell dependency, a kinetic analysis was performed showing increased levels of FoxP3+CD25+CD4+ T cells. Inactivation of these Treg cells resulted in loss of protection. Adoptive transfer of the vaccine-induced Treg cells protected mice against EAE with greater potency than naive or Salmonella vector-induced Treg cells, and cytokine analysis revealed enhanced production of TGF-beta, not IL-10. The development of these Treg cells in conjunction with immune deviation by Th2 cells optimally induced protective Treg cells when compared those induced in the absence of Th2 cells. These data show that Treg cells can be induced to high potency to non-disease-inducing Ags using a bacterial vaccine.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Public Health Service Grant AI-41123 and in part by Montana Agricultural Station and U.S. Department of Agriculture Formula Funds. The Veterinary Molecular Biology flow cytometry facility was in part supported by National Institutes of Health/National Center for Research Resources Centers of Biomedical Research Excellence P20 RR-020185.

2 Address correspondence and reprint requests to Dr. David W. Pascual, Veterinary Molecular Biology, P.O. Box 173610, Montana State University, Bozeman, MT 59717-3610. E-mail address: dpascual{at}montana.edu

3 Abbreviations used in this paper: MS, multiple sclerosis; CFA/I, colonization factor Ag I; CLN, cervical lymph node; CM, complete medium; EAE, experimental autoimmune encephalomyelitis; HNLN, head and neck lymph node; LFB, luxol fast blue; MLN, mesenteric lymph node; PLP, protein proteolipid; PP, Peyer patches; PT, Bordetella pertussis toxin; SMLN, submaxillary gland lymph node; Teff, effector T; Treg, regulatory T.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Ochoa-Reparaz, D. W. Mielcarz, L. E. Ditrio, A. R. Burroughs, D. M. Foureau, S. Haque-Begum, and L. H. Kasper
Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis
J. Immunol., November 15, 2009; 183(10): 6041 - 6050.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. R. Jang, M. T. Gandolfo, G. J. Ko, S. Satpute, L. Racusen, and H. Rabb
Early exposure to germs modifies kidney damage and inflammation after experimental ischemia-reperfusion injury
Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1457 - F1465.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. Yamanaka, T. Hoyt, X. Yang, S. Golden, C. M. Bosio, K. Crist, T. Becker, M. Maddaloni, and D. W. Pascual
A Nasal Interleukin-12 DNA Vaccine Coexpressing Yersinia pestis F1-V Fusion Protein Confers Protection against Pneumonic Plague
Infect. Immun., October 1, 2008; 76(10): 4564 - 4573.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Kochetkova, T. Trunkle, G. Callis, and D. W. Pascual
Vaccination without Autoantigen Protects against Collagen II-Induced Arthritis via Immune Deviation and Regulatory T Cells
J. Immunol., August 15, 2008; 181(4): 2741 - 2752.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Ochoa-Reparaz, A. Rynda, M. A. Ascon, X. Yang, I. Kochetkova, C. Riccardi, G. Callis, T. Trunkle, and D. W. Pascual
IL-13 Production by Regulatory T Cells Protects against Experimental Autoimmune Encephalomyelitis Independently of Autoantigen
J. Immunol., July 15, 2008; 181(2): 954 - 968.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Rynda, M. Maddaloni, D. Mierzejewska, J. Ochoa-Reparaz, T. Maslanka, K. Crist, C. Riccardi, B. Barszczewska, K. Fujihashi, J. R. McGhee, et al.
Low-Dose Tolerance Is Mediated by the Microfold Cell Ligand, Reovirus Protein {sigma}1
J. Immunol., April 15, 2008; 180(8): 5187 - 5200.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Ochoa-Reparaz, J. Sentissi, T. Trunkle, C. Riccardi, and D. W. Pascual
Attenuated Coxiella burnetii Phase II Causes a Febrile Response in Gamma Interferon Knockout and Toll-Like Receptor 2 Knockout Mice and Protects against Reinfection
Infect. Immun., December 1, 2007; 75(12): 5845 - 5858.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.